MICROPORT NEURO (02172) saw its stock price plummet by 5.38% in the pre-market session on Thursday, following the release of its 2025 interim results. The neuro-intervention device maker reported a significant decline in profits, which appears to have spooked investors.

According to the company's financial report, MICROPORT NEURO's profit attributable to equity shareholders for the first half of 2025 fell to RMB 92.923 million, representing a substantial 35.25% decrease compared to the same period last year. The company's revenue also took a hit, declining by 6.2% year-on-year to approximately RMB 383 million. These disappointing figures likely contributed to the sharp drop in stock price.

Despite the overall negative results, there were some bright spots in the report. The company's international business showed strong growth momentum, with overseas revenue surging by 67.4% year-on-year to RMB 47.1 million. MICROPORT NEURO has successfully launched 8 products internationally and achieved commercialization in 34 overseas countries and regions. This expansion into global markets could potentially offer some optimism for long-term investors, although it wasn't enough to offset the immediate reaction to the profit decline.